FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth subsidiary C³ Group.
C³ specialises...
COMBINED sales of the three most lucrative cannabis pharmaceuticals products - Epidiolex, Dronabinol and Sativex - are set to reach €1.8 billion by 2025,...
THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals announced in the last few months.
Over the...
PRESS RELEASE
FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...